Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2007;100:645-653
Published online before print February 15, 2007, doi: 10.1161/01.RES.0000260203.55077.61
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Data Supplement
Right arrow All Versions of this Article:
100/5/645    most recent
01.RES.0000260203.55077.61v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Merkle, S.
Right arrow Articles by Engelhardt, S.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Merkle, S.
Right arrow Articles by Engelhardt, S.
Right arrowPubmed/NCBI databases
*Gene*GEO Profiles
*HomoloGene*Nucleotide
*Protein*UniGene
Medline Plus Health Information
*Heart Failure
Related Collections
Right arrow Other myocardial biology
Right arrow Other heart failure
Right arrow Hypertrophy
Right arrow Animal models of human disease
Right arrow Apoptosis
Right arrow Physiological and pathological control of gene expression
(Circulation Research. 2007;100:645.)
© 2007 American Heart Association, Inc.


Molecular Medicine

A Role for Caspase-1 in Heart Failure

Sabine Merkle, Stefan Frantz, Michael P. Schön, Johann Bauersachs, Monika Buitrago, Robert J.A. Frost, Eva M. Schmitteckert, Martin J. Lohse, Stefan Engelhardt

From the Rudolf Virchow Center (S.M., M.P.S., M.B., R.J.A.F., S.E.), Deutsche Forschungsgemeinschaft-Research Center for Experimental Biomedicine; Department of Internal Medicine (S.F., J.B.); Department of Dermatology, Venereology and Allergology (M.P.S.); and Institute of Pharmacology and Toxicology (E.S., M.J.L.), University of Wuerzburg, Germany.

Correspondence to Stefan Engelhardt, MD PhD, Rudolf Virchow Center, DFG-Research Center for Experimental Biomedicine, University of Wuerzburg, Versbacher Strasse 9, 97078 Wuerzburg, Germany. E-mail stefan.engelhardt{at}virchow.uni-wuerzburg.de

Apoptosis of cardiomyocytes is increased in heart failure and has been implicated in disease progression. The activation of "proapoptotic" caspases represents a key step in cardiomyocyte apoptosis. In contrast, the role of "proinflammatory" caspases (caspases 1, 4, 5, 11, 12) is unclear. Here, we study the cardiac function of caspase-1. Gene array analysis in a murine heart failure model showed upregulation of myocardial caspase-1. In addition, we found increased expression of caspase-1 protein in murine and human heart failure. Mice with cardiomyocyte-specific overexpression of caspase-1 developed heart failure in the absence of detectable formation of interleukin (IL)-1ß or IL-18 and inflammation. Transgenic caspase-1 induced primary cardiomyocyte apoptosis before structural and molecular signs of myocardial remodeling occurred. In contrast, deletion of endogenous caspase-1 was beneficial in the setting of myocardial infarction–induced heart failure. Furthermore, caspase-1–deficient mice were protected from ischemia/reperfusion-induced cardiomyocyte apoptosis. Studies in primary rat cardiomyocytes indicated that caspase-1 induces cardiomyocyte apoptosis primarily through activation of caspases-3 and -9. In contrast to previous findings, which imply a proinflammatory role of caspase-1, these data suggest a primary proapoptotic role for caspase-1 in cardiomyocytes. Our findings support a functional role for caspase-1–mediated myocardial apoptosis contributing to the progression of heart failure.


Key Words: caspase-1 • transgenic mouse • heart failure




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
E. J. Birks, N. Latif, K. Enesa, T. Folkvang, L. A. Luong, P. Sarathchandra, M. Khan, H. Ovaa, C. M. Terracciano, P. J.R. Barton, et al.
Elevated p53 expression is associated with dysregulation of the ubiquitin-proteasome system in dilated cardiomyopathy
Cardiovasc Res, August 1, 2008; 79(3): 472 - 480.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
A. Abbate, F. N. Salloum, E. Vecile, A. Das, N. N. Hoke, S. Straino, G. G.L. Biondi-Zoccai, J.-E. Houser, I. Z. Qureshi, E. D. Ownby, et al.
Anakinra, a Recombinant Human Interleukin-1 Receptor Antagonist, Inhibits Apoptosis in Experimental Acute Myocardial Infarction
Circulation, May 20, 2008; 117(20): 2670 - 2683.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. J.A. Frost and S. Engelhardt
A Secretion Trap Screen in Yeast Identifies Protease Inhibitor 16 as a Novel Antihypertrophic Protein Secreted From the Heart
Circulation, October 16, 2007; 116(16): 1768 - 1775.
[Abstract] [Full Text] [PDF]